HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 233/12/1554    most recent 0807-RM-221v1 Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Choi, H. J. Articles by Park, J. H. Y. PubMed PubMed Citation Articles by Choi, H. J. Articles by Park, J. H. Y.

---

ORIGINAL RESEARCH ARTICLE

Hexane/Ethanol Extract of Glycyrrhiza uralensis Licorice Suppresses Doxorubicin-Induced Apoptosis in H9c2 Rat Cardiac Myoblasts

Hyun Ju Choi^*, Mi Ra Seon^*, Soon Sung Lim^*, Jong-Sang Kim, Hyang Sook Chun and Jung Han Yoon Park^*,1

^* Department of Food Science and Nutrition, Hallym University, Chuncheon 200-702, Republic of Korea; Department of Animal Science and Biotechnology, Kyungpook National University, Deagu 702-701, Republic of Korea; and Korea Food Research Institute, Songnam 463-746, Republic of Korea

To whom requests for reprints should be addressed at ¹ Department of Food Science and Nutrition, Hallym University, Chuncheon 200-702, South Korea. E-mail: jyoon{at}hallym.ac.kr

Doxorubicin (DOX) is an anthracycline antibiotic, and has been recognized as one of the most effective anti-neoplastic agents in cancer chemotherapy. However, its usefulness is limited by its profound cardiotoxicity. Licorice is one of the most frequently prescribed agents in traditional herbal medicine, and is also employed as a natural sweetening additive. In traditional Chinese medicine, licorice root is added to a variety of herbal preparations to detoxify the effects of the other herbs in the preparation. In the present study, we explored the possibility that Glycyrrhiza uralensis licorice may alleviate DOX-induced cardiotoxicity. The hexane/ethanol extract of Glycyrrhiza uralensis (HEGU), which lacks glycyrrhizin, was prepared because glycyrrhizin intake has previously been reported to induce hypertension. In an effort to determine whether HEGU ameliorates DOX-induced cytotoxicity in H9c2 rat cardiac myoblasts, the cells were pretreated with 0–15 mg/L HEGU, then treated with doxorubicin. The pretreatment of cells with HEGU resulted in a significant mitigation of DOX-induced reductions in cell numbers (34 ± 7%) and increases in apoptosis (53 ± 1%). The Western blot analysis of cell lysates showed that HEGU suppressed DOX-induced increases in the levels of p53, phospho-p53 (Ser 15), and Bax. In addition, HEGU induced an increase in the levels of Bcl-xL, regardless of DOX-treatment. HEGU inhibited the DOX-induced cleavage of caspases 9, 3, and 7, as well as DOX-induced poly(ADP-ribose) polymerase cleavage. Furthermore, HEGU caused reductions in the viable cell numbers of HT-29 human colon cancer cells (IC50 = 10.7 ± 0.3 mg/L), MDA-MB-231 human breast cancer cells (IC50 = 7.5 ± 0.1 mg/L), and DU145 human prostate cancer cells (IC50 = 4.7 ± 0.5 mg/L). HEGU augmented DOX-induced reductions in the viability of DU145 cells (15 ± 1%). These results indicate that HEGU may potentially be an effective agent for the alleviation of DOX-induced cardiotoxicity.

Key Words: licorice • doxorubicin • cardiotoxicity • apoptosis